<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Stockholm_Labbook skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Stockholm/Labbook</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="post-template nav-closed"><DIV class="navigation"><DIV class="nav-content"><DIV class="nav-items"><DIV class="nav-project" role="presentation"><A href="/Team:Stockholm/Description">Project</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/Description#inshort">In Short</A><A href="/Team:Stockholm/Description#ourpath">Our Path</A><A href="/Team:Stockholm/Description#biofilm">Background</A><A href="/Team:Stockholm/Description#ourproject">Our Project</A><A href="/Team:Stockholm/Description#combatproteins">Combat Proteins</A><A href="/Team:Stockholm/Description#sortasea">Sortase A</A><A href="/Team:Stockholm/Future">Future</A><A href="/Team:Stockholm/Medals">Medal achievements</A></DIV></DIV><DIV class="nav-parts" role="presentation"><A href="/Team:Stockholm/Parts">Parts</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/Parts">All parts</A><A href="/Team:Stockholm/Basic_Parts">Basic Parts</A><A href="/Team:Stockholm/Part_Collection">Part Collection</A></DIV></DIV><DIV class="nav-wet-lab" role="presentation"><A href="/Team:Stockholm/Experiments">Lab</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/Experiments">Experiments</A><A href="/Team:Stockholm/Labbook">Lab book</A><A href="/Team:Stockholm/Protocols">Protocols</A></DIV></DIV><DIV class="nav-results" role="presentation"><A href="/Team:Stockholm/Proof">Results</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/Proof">Proof of concept</A><A href="/Team:Stockholm/Results-nuc">Nuc</A><A href="/Team:Stockholm/Results-lys">Lys</A><A href="/Team:Stockholm/Results-def">Def</A><A href="/Team:Stockholm/Results-esp">Esp</A><A href="/Team:Stockholm/Results-sortase-a">Sort A</A></DIV></DIV><DIV class="nav-team" role="presentation"><A href="/Team:Stockholm/Team">Team</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/Team">Members</A><A href="/Team:Stockholm/Collaborations">Collaborations</A><A href="/Team:Stockholm/Attributions">Attributions</A><A href="/Team:Stockholm/Sponsors">Sponsors</A><A href="/Team:Stockholm/Diary">Diary</A></DIV></DIV><DIV class="nav-practises" role="presentation"><A href="/Team:Stockholm/HP/Silver">Human Practices</A><DIV class="nav-sublevel"><A href="/Team:Stockholm/HP/Silver">CARD</A><A href="/Team:Stockholm/HP/Gold">TECH</A><A href="/Team:Stockholm/Integrated_practices">Integrated</A><A href="/Team:Stockholm/Engagement">Engagement</A></DIV></DIV><DIV class="nav-safety" role="presentation"><A href="/Team:Stockholm/Safety">Safety</A></DIV><DIV class="nav-nic" role="presentation"><A href="/Team:Stockholm/NiC">NiC</A></DIV></DIV></DIV></DIV></DIV><DIV class="site-wrapper post-template"><MAIN class="content"><ARTICLE class="post"><HEADER class="post-header"><H1 class="post-title">Lab books</H1></HEADER><SECTION class="post-content"><P>Hover over a week for a protein to see a summary. Click to view the actual lab book (a PDF in a new page). See our <A href="https://static.igem.org/mediawiki/2016/a/a8/T--Stockholm--abbreviations_list.pdf" target="_blank">Abbreviations</A> to view and understand them throughout the lab books!  </P><TABLE><THEAD><TR><TD>Nuc</TD><TD>Lys</TD><TD>Esp</TD><TD>Def</TD><TD>Sort A</TD></TR></THEAD><TBODY><TR><TD summary="The goal of this week was to confirm the BioBrick ordered from iGEM HQ by preparing for sequencing."><A href="https://static.igem.org/mediawiki/2016/8/8e/T--Stockholm--nuc_week_1.pdf" target="_blank">Week 1</A></TD><TD summary="To be able to actively work with lysostaphin, we first amplified the biobrick present in the distribution kit by  transformation of E.coli TOP10."><A href="https://static.igem.org/mediawiki/2016/2/2f/T--Stockholm--lys_week_1.pdf" target="_blank">Week 1</A></TD><TD summary="We used PCR to confirm the size of the insert and sent samples for sequencing."><A href="https://static.igem.org/mediawiki/2016/2/2e/T--Stockholm--esp_week_1.pdf" target="_blank">Week 1</A></TD><TD summary="The defensin BioBrick from iGEM HQ was prepared and sent for sequencing."><A href="https://static.igem.org/mediawiki/2016/4/49/T--Stockholm--def_week_1.pdf" target="_blank">Week 1</A></TD><TD summary="Testing conjugation between two proteins using commercial available Sortase."><A href="https://static.igem.org/mediawiki/2016/e/ea/T--Stockholm--Sortase_week_1.pdf" target="_blank">Week 1</A></TD></TR><TR><TD summary="Preparing digestion of T7 and Nuc for 3A assembly. The Nuc gel ran for too long and was lost, so we had to re-do the PCR of Nuc."><A href="https://static.igem.org/mediawiki/2016/4/49/T--Stockholm--nuc_week_3.pdf" target="_blank">Week 3</A></TD><TD summary="  
To obtain a construct that could be transcribed into a fully functional protein, a promoter must be placed prior to the lysostaphin coding sequence. To accomplish this, we have chosen to place a T7 promoter by means of 3A assembly with pSB1K3 as the new backbone.  
"><A href="https://static.igem.org/mediawiki/2016/a/a3/T--Stockholm--lys_week_3.pdf" target="_blank">Week 3</A></TD><TD summary="We performed 3A assembly to incorporate T7 promoter with Esp (both EB and EC) and put into kanamycin backbone. The new construct was transformed and prepared for sequencing.  
"><A href="https://static.igem.org/mediawiki/2016/3/3c/T--Stockholm--esp_week_3.pdf" target="_blank">Week 3</A></TD><TD summary="We aimed make glycerol stocks of S.aureus newman strain and to extract the genome of the bacteria."><A href="https://static.igem.org/mediawiki/2016/5/5f/T--Stockholm--Sortase_week_3.pdf" target="_blank">Week 3</A></TD></TR><TR><TD summary="The PCR from the previous week contained Esp, and not Nuc. We digested more Nuc and ran a gel to confirm. After gel purification of Nuc, the concentrations of Nuc were too low. Hence we needed to amplify more Nuc.  
"><A href="https://static.igem.org/mediawiki/2016/6/6e/T--Stockholm--nuc-week-4.pdf" target="_blank">Week 4</A></TD><TD summary="Performed digestions and re-assembled the pSB1K3-T7-Lys construct."><A href="https://static.igem.org/mediawiki/2016/a/a0/T--Stockholm--lys_week_4.pdf" target="_blank">Week 4</A></TD><TD summary="PCR showed that both T7-EB and T7-EC had correct size but after sequencing, only EB was found to be correctly assembled. We abandoned CB and tried to induce the EB protein expression by IPTG induction.  
"><A href="https://static.igem.org/mediawiki/2016/4/48/T--Stockholm--esp_week_4.pdf" target="_blank">Week 4</A></TD></TR><TR><TD summary="Cells containing pSB1C3-Nuc from iGEM HQ was inoculated in liquid media. It was then extracted and digested. pSB1K3-T7-EB was also digested, as a backbone source.  
"><A href="https://static.igem.org/mediawiki/2016/c/c7/T--Stockholm--nuc_week_5.pdf" target="_blank">Week 5</A></TD><TD summary="Performed further analysis of the pSB1K3-T7-Lys construct previously assembled. Began with overhang PCR to add BamHI site for addition of linker tags."><A href="https://static.igem.org/mediawiki/2016/8/83/T--Stockholm--lys_week_5.pdf" target="_blank">Week 5</A></TD><TD summary="We re-did the transformation, induced the protein expression at different conditions and performed the first SDS-page. We found a slightly increased band after induction, which had similar size and might be the EB. The first overhang PCR was tried as the initial step for connecting with linker tag. But it failed."><A href="https://static.igem.org/mediawiki/2016/b/b2/T--Stockholm--esp_week_5.pdf" target="_blank">Week 5</A></TD><TD summary="Aimed to Isolate a truncated version of Sortase A from the S. aureus genome and then further assemble the fragment with the solubility tag GB1 through a Gibson assembly (first set of trials)."><A href="https://static.igem.org/mediawiki/2016/2/28/T--Stockholm--Sortase_week_5.pdf" target="_blank">Week 5</A></TD></TR><TR><TD summary="  
3A assemblies performed were successful. However, the first attempted transformation of pSB1K3-T7-Nuc in TOP10 cells was not successful. To increase the chances of transforming we aimed to increase the concentration of Nuc in our final samples, After several attempts we transformed successfully. However, when running a gel on the transformed DNA, it seemed to EB."><A href="https://static.igem.org/mediawiki/2016/8/8f/T--Stockholm--nuc_week_6.pdf" target="_blank">Week 6</A></TD><TD summary="After having transformed pSB1K3-T7-Lys in the previous week, protein expression was started this week. Gel purification of overhang PCR product with BamHI was performed so that the linker-tag sequence could be added in. To ensure the correct gene expression, the products were sent for sequencing."><A href="https://static.igem.org/mediawiki/2016/1/14/T--Stockholm--lys_week_6.pdf" target="_blank">Week 6</A></TD><TD summary="Troubleshooting of the overhang PCR, different conditions were tested. Unfortunately, none of them succeeded, the bands were either faint or unspecific.  
Another two SDS-page was done to prove the expression of EB. Strong bands were observed at roughly the correct size after induction. EB seemed to be expressed in insoluble form."><A href="https://static.igem.org/mediawiki/2016/a/a1/T--Stockholm--esp_week_6.pdf" target="_blank">Week 6</A></TD><TD summary="After last weeks failed attempts to perform a Gibson assembly, a new strategy, Overlap extension PCR, was tried to join the solubility tag GB1 and SortA. Joint fragments were then digested in preparation for a ligation into a pSB1A3 vector."><A href="https://static.igem.org/mediawiki/2016/e/ea/T--Stockholm--Sortase_labbook_week_6.pdf" target="_blank">Week 6</A></TD></TR><TR><TD summary="This week we extracted pSB1K3-T7-Nuc from transformed BL21(DE3) cells. However, the gel showed bands with sizes not consistent with Nuc. The transformation most likely did not work due to unsuccessful 3A assembly, or the transformation itself might not have worked. Attempts of assembling a pSB1A3-T7-Nuc were made."><A href="https://static.igem.org/mediawiki/2016/1/1e/T--Stockholm--nuc_week_7.pdf" target="_blank">Week 7</A></TD><TD summary="At this point we have confirmed that the construct we have been working with is in actual fact 3A Assembled Esp Basic. Thus, to avoid further cross-contamination of samples, we decided to work with lysostaphin from the beginning, that being the BioBrick present in the plasmid. Hence, the aim of this week was to obtain 3A assembled lysostaphin constructs of pSB1C3-T7-Lys."><A href="https://static.igem.org/mediawiki/2016/d/d1/T--Stockholm--lys_week_7.pdf" target="_blank">Week 7</A></TD><TD summary="We realized that the primers were mixed up between EB and EC. Then we did overhang PCR with the correct primers and got strong bands at correct size. The problem with overhang PCR of EB was solved. We continued with digestion and ligation with linker tag but It didn’t succeed."><A href="https://static.igem.org/mediawiki/2016/d/d9/T--Stockholm--esp_week_7.pdf" target="_blank">Week 7</A></TD><TD summary="The pSB1C3-Def was extracted from liquid cultures and PCR amplified."><A href="https://static.igem.org/mediawiki/2016/1/1d/T--Stockholm--defensin_week_7.pdf" target="_blank">Week 7</A></TD><TD summary="Focused on changing the Backbone to a pSB1C3 one, but also fixing details in the sequence such as adding the full prefix and suffix. We also transformed the new ligation product. The ligation was deemed unsuccessful after analysis."><A href="https://static.igem.org/mediawiki/2016/7/74/T--Stockholm--sort_week_7.pdf" target="_blank">Week 7</A></TD></TR><TR><TD summary="We digested pSB1C3-Nuc from week 5, and even though the concentrations were low we could use it for 3A-assembly of pSB1C3-T7-Nuc. We later found out that digestion had been done with incorrect digestion enzymes, resulting in invalid results this week."><A href="https://static.igem.org/mediawiki/2016/c/ca/T--Stockholm--nuc_week_8.pdf" target="_blank">Week 8</A></TD><TD summary="Retried 3A assembly of pSB1C3-T7-Lys with success. The construct was subjected to overhang PCR to add BamHI and was also expressed in BL21(DE3)."><A href="https://static.igem.org/mediawiki/2016/d/d6/T--Stockholm--lys_week_8.pdf" target="_blank">Week 8</A></TD><TD summary="Kirby-Bauer test showed EB might have bactericidal activity. Troubleshooting for digestion and ligation of T7-EB with linkertag, none of them worked. We tried to improve the EB biobrick by making truncated version, it was unsuccessful unfortunately."><A href="https://static.igem.org/mediawiki/2016/d/d7/T--Stockholm--esp_week_8.pdf" target="_blank">Week 8</A></TD><TD summary="Attempts of 3A assembling pSB1C3-T7-Def constructs were successful."><A href="https://static.igem.org/mediawiki/2016/a/aa/T--Stockholm--defensin_week_8.pdf" target="_blank">Week 8</A></TD><TD summary="We continued to focus on changing the backbone in which the overlap extension PCR product is in and then further transform. Colonies were picked and analysed. Negative PCR results were apprehended from the colony PCR and sequencing results were not as expected."><A href="https://static.igem.org/mediawiki/2016/1/1b/T--Stockholm--sort_week_8.pdf" target="_blank">Week 8</A></TD></TR><TR><TD summary="Gel of pSB1C3-T7-Nuc seems correct. Will be sent for sequencing to identify the construct. A BamHI restriction site was successfully added to the construct using overhang PCR amplification. Results from assembly of a pSB1C3-T7-Nuc-BamHI-LT construct were inconclusive."><A href="https://static.igem.org/mediawiki/2016/d/d6/T--Stockholm--nuc_week_9.pdf" target="_blank">Week 9</A></TD><TD summary="This week we mainly focused on characterizing the expressed construct. This was done by an SDS Page and a Kirby Bauer test on *E.coli* TOB1. More attempts of adding the linker tag was also performed by means of constructing pSB1C3-T7-Lys-LT."><A href="https://static.igem.org/mediawiki/2016/8/82/T--Stockholm--lysostaphin_week_9.pdf" target="_blank">Week 9</A></TD><TD summary="Kirby-Bauer test on EB. Troubleshooting for digestion and ligation, one colony developed but with incorrect sequence. "><A href="https://static.igem.org/mediawiki/2016/7/74/T--Stockholm--esp_week_9.pdf" target="_blank">Week 9</A></TD><TD summary="Assembled pSB1C3-T7-Def construct was transformed into TOP10 cells and successfully confirmed through several analyzes."><A href="https://static.igem.org/mediawiki/2016/3/30/T--Stockholm--defensin_week_9.pdf" target="_blank">Week 9</A></TD><TD summary="Several attempts to ligate the joined gene fragments into the pSB1C3 Backbone. Transformation was tried out in electro-competent cells. Colonies were grew and were analyzed through colony PCR and sequencing which gave negative results"><A href="https://static.igem.org/mediawiki/2016/f/fc/T--Stockholm--sortase_week_9.pdf" target="_blank">Week 9</A></TD></TR><TR><TD summary="BL21(DE3) cells containing pSB1C3-T7-Lys was further characterized by colony picking and expression.  "><A href="https://static.igem.org/mediawiki/2016/7/79/T--Stockholm--lysostaphin_week_10.pdf" target="_blank">Week 10</A></TD><TD summary="Colony PCR was carried out on the remaining colonies on plates form last week to confirm insert. The results were not as desired."><A href="https://static.igem.org/mediawiki/2016/8/88/T--Stockholm--sortase_week_10.pdf" target="_blank">Week 10</A></TD></TR><TR><TD summary="pSB13C-T7-Nuc containing BL21(DE3) cells were inoculated and protein expression was induced. The bactericolytic activity of nuclease was analysed with a Kirby-Bauer test."><A href="https://static.igem.org/mediawiki/2016/4/4c/T--Stockholm--nuc-week-11.pdf" target="_blank">Week 11</A></TD></TR><TR><TD summary="We had confirmed that pSB1C3-T7-Lys-LT that had been successfully assembled had not contained the LT, therefore we re-checked the sequence of this construct with PCR. "><A href="https://static.igem.org/mediawiki/2016/8/81/T--Stockholm--lys_week_12.pdf" target="_blank">Week 12</A></TD></TR><TR><TD summary="New method attempted for the assembly of a pSB1C3-T7-Nuc-BamHI-LT construct."><A href="https://static.igem.org/mediawiki/2016/e/ec/T--Stockholm--nuc_week_14.pdf" target="_blank">Week 14</A></TD><TD summary="Attempts of of adding the BamHI site by performing the overhang PCR strategy 2 was performed with different conditions. "><A href="https://static.igem.org/mediawiki/2016/9/9d/T--Stockholm--lys_week_14.pdf" target="_blank">Week 14</A></TD><TD summary="T7-EB was changed to the chloramphenicol backbone. "><A href="https://static.igem.org/mediawiki/2016/c/c7/T--Stockholm--esp_week_14.pdf" target="_blank">Week 14</A></TD><TD summary="Started over with the design of assembling the Sortase A Biobrick since a few lacking features were identified in the experimental design. Freshly designed primers and gBlocks were ordered to try out Gibson assembly again (second set of trials) and if it turned out unsuccessful continue with Overlap extension PCR. Two failed trials of Gibson assembly were performed before moving on to Overlap extension PCR again.  
"><A href="https://static.igem.org/mediawiki/2016/1/1d/T--Stockholm--sortase_week_14.pdf" target="_blank">Week 14</A></TD></TR><TR><TD summary="Additional eight attempts with the new method of assembling a pSB1C3-T7-Nuc-BamHI-LT construct. A Kirby-Bauer test was performed of earlier expressed nuclease."><A href="https://static.igem.org/mediawiki/2016/1/17/T--Stockholm--nuc_week_15.pdf" target="_blank">Week 15</A></TD><TD summary="Attempts of of adding the BamHI site was optimised by varying several parameters, however with the attempts we had tried it had been successful. "><A href="https://static.igem.org/mediawiki/2016/e/ec/T--Stockholm--lys_week_15.pdf" target="_blank">Week 15</A></TD><TD summary="We performed overhang PCR on EB with new strategy with different annealing temperature. But none of them succeeded. First biofilm assay on EB, It showed positive effect in dispersing the biofilm."><A href="https://static.igem.org/mediawiki/2016/7/76/T--Stockholm--Esp_week_15.pdf" target="_blank">Week 15</A></TD><TD summary="The first step, adding a BamHI restriction site through overhang PCR amplification, in the assembly of the pSB1C3-T7-Def-BamHI-LT construct was successfully performed."><A href="https://static.igem.org/mediawiki/2016/1/14/T--Stockholm--def_week_15.pdf" target="_blank">Week 15</A></TD><TD summary="Overlap extension PCR of to join the two fragments of interest. They were later digested on the ends and ligated into a pSB1C Backbone, followed by a successful transformation."><A href="https://static.igem.org/mediawiki/2016/b/b0/T--Stockholm--sortase_week_15.pdf" target="_blank">Week 15</A></TD></TR><TR><TD summary="Biofilm dispersal and inhibition by expressed nuclease was investigated with biofilm assays."><A href="https://static.igem.org/mediawiki/2016/e/e5/T--Stockholm--nuc-week-16.pdf" target="_blank">Week 16</A></TD><TD summary="The biofilm assay was performed on cell lysates containing lys and this was done to observe the inhibitory and dispersal capability of Lys. "><A href="https://static.igem.org/mediawiki/2016/2/2a/T--Stockholm--lys_labbook_week16.pdf" target="_blank">Week 16</A></TD><TD summary="We modified the method and redid the biofilm assay. The bactericidal effect of EB was not clear but EB was potent in dispersing biofilm.  
We tried overhang PCR with new strategy on EB but failed."><A href="https://static.igem.org/mediawiki/2016/c/cf/T--Stockholm--esp_labbook_week16.pdf" target="_blank">Week 16</A></TD><TD summary="The activity of earlier expressed defensin in biofilm dispersal and inhibition was analysed with biofilm assays. Also, the pSB1C3-T7-Def-BamHI-LT construct was successfully assembled. Defensin with added Sortase and His tag was successfully expressed in BL21(DE3) cells, extracted and purified. The tagged defensin was further successfully conjugated to spider silk protein."><A href="https://static.igem.org/mediawiki/2016/c/c6/T--Stockholm--def-week-16_%281%29.pdf" target="_blank">Week 16</A></TD><TD summary="Testing conjugation between two proteins using commercial available Sortase.

Liquid cultures were made of the colonies from last week followed by plasmid purification.  
Site directed mutagenesis was tried on extracted plasmid but failed. "><A href="https://static.igem.org/mediawiki/2016/f/f7/T--Stockholm--Sortase_week_16.pdf" target="_blank">Week 16</A></TD></TR></TBODY></TABLE></SECTION></ARTICLE></MAIN></DIV><FOOTER class="site-footer clearfix"><SECTION class="sponsors">
    iGEM Stockholm is sponsored by
    </SECTION></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>